PerkinElmer Inc (NYSE:PKI)

77.02
Delayed Data
As of Feb 23
 +1.06 / +1.40%
Today’s Change
53.97
Today|||52-Week Range
84.49
+5.33%
Year-to-Date
Here's Why You Should Invest in LabCorp (LH) Stock Right Now
Feb 23 / Zacks.com - Paid Partner Content
Allscripts (MDRX) Q4 Earnings Meet, Revenues Beat Estimates
Feb 16 / Zacks.com - Paid Partner Content
Cardinal Health Strong on Medical & Pharmaceutical Segments
Feb 23 / Zacks.com - Paid Partner Content
Chemed (CHE) Beats on Q4 Earnings & Revenues, Issues View
Feb 15 / Zacks.com - Paid Partner Content
Medtronic (MDT) Unveils MiniMed Mio Advance Infusion Set
Feb 23 / Zacks.com - Paid Partner Content
5 Reasons Why You Should Buy CONMED (CNMD) Stock Right Now
Feb 15 / Zacks.com - Paid Partner Content
Integer Holdings (ITGR) Beats on Q4 Earnings, Issues '18 View
Feb 23 / Zacks.com - Paid Partner Content
GNC Holdings to Boost International Business With New Deals
Feb 14 / Zacks.com - Paid Partner Content
Here's Why You Should Keep Omnicell (OMCL) in Your Portfolio
Feb 22 / Zacks.com - Paid Partner Content
GNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue Estimates
Feb 14 / Zacks.com - Paid Partner Content
5 Reasons Why You Should Add Becton, Dickinson (BDX) Now
Feb 22 / Zacks.com - Paid Partner Content
DaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues
Feb 14 / Zacks.com - Paid Partner Content
Here's Why You Should Invest in Edwards Lifesciences (EW) Now
Feb 22 / Zacks.com - Paid Partner Content
Myriad Genetics' Positive Study Data May Expand Customer Base
Feb 13 / Zacks.com - Paid Partner Content
Ecolab (ECL) Misses Q4 Earnings Estimates, View Impressive
Feb 20 / Zacks.com - Paid Partner Content
5 Reasons to Invest in PerkinElmer (PKI) Stock Right Now
Feb 13 / Zacks.com - Paid Partner Content
Henry Schein (HSIC) Q4 Earnings in Line, 2018 View Upbeat
Feb 20 / Zacks.com - Paid Partner Content
Luminex (LMNX) Beats on Q4 Earnings & Revenues, Issues View
Feb 13 / Zacks.com - Paid Partner Content
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
Feb 20 / Zacks.com - Paid Partner Content
Here's Why You Should Sweep Up Quest Diagnostics Right Now
Feb 13 / Zacks.com - Paid Partner Content
Medtronic (MDT) Beats on Q3 Earnings, Reiterates FY18 View
Feb 20 / Zacks.com - Paid Partner Content
Becton, Dickinson Gains on Strong Q1 Results & Acquisitions
Feb 13 / Zacks.com - Paid Partner Content
Myriad Genetics Banks on Product Launches, Competition Rife
Feb 19 / Zacks.com - Paid Partner Content
Amedisys (AMED) Strong on Home Health, Margin Decline a Woe
Feb 12 / Zacks.com - Paid Partner Content
Abiomed Hits New 52-Week High: 4 Factors Driving the Stock
Feb 19 / Zacks.com - Paid Partner Content
QIAGEN's QFT-Plus Approval in Japan to Expand Customer Base
Feb 12 / Zacks.com - Paid Partner Content
Edwards Lifesciences' CE Mark for CENTERA Boosts THVT Arm
Feb 16 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Banks on Plasma Franchise, Competition Rife
Feb 12 / Zacks.com - Paid Partner Content
Cardiovascular Systems Portfolio Solid, Competition Rife
Feb 16 / Zacks.com - Paid Partner Content
Abbott's FreeStyle LibreLink App Now Available in Europe
Feb 12 / Zacks.com - Paid Partner Content
Medtronic's Positive Study Results May Expand Customer Base
Feb 16 / Zacks.com - Paid Partner Content